OS Therapies Files for $10 Million IPO
OS Therapies, a clinical-stage biotech company, has filed for an initial public offering (IPO) of 2 million shares at $5 per share. The company intends to raise $10 million in gross proceeds from the offering. The IPO filing was made with the Securities and Exchange Commission (SEC) on [insert date]..